The Drug-Induced Cardiotoxicity Website and App

XXII.e

XXII - Acute respiratory/cardiorespiratory failure

Respiratory failure from ventilatory depression (due to neuromuscular blockade/paralysis)

Last update 23/10/2023

Presentation may range from restrictive lung dysfunction to acute respiratory failure with an increased PaCO2 and respiratory acidosis and blunted ventilatory reponse to hypoxia and/or hypercarbia. Aspiration, brain damage and death can occur (See PMID 25536092). See also under IXi, IXIe, IXa, IXj, IXs

Causative drugs

24

Frequency - Incidence

Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.a
I.d
I.g
III.c
XI.b
XII.b
XII.g
XIV.a
XIV.h
XV.b
XVI.e
XVI.i
XXII.b
XXII.d
XXIV.a
XXIV.b
XXIV.c
XXIV.d
XXIV.e
XXIV.f
XXIV.g
XXIV.h
XXIV.k
XXIV.m
XXIV.n
XXIV.o
XXIV.p
XXIV.q
XXIV.r
XXIV.s
XXIV.aa
XXIV.ac
XXV.g
XXVI.b
XXVI.d
XXVIII.a
XXVIII.h
XXIX.d
XXX.i
XXX.l
XXX.o
XXX.p
XXX.r
XXXI.f
XXXI.g
XXXIII.k
XXXIII.y
XXXIV.g
XXXVI.f
XXXVI.p
XXXVIII.g
Loading more…